- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03146598
Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders (SPS-AFO)
May 5, 2017 updated by: BERTHILLIER Julien
Use and Tolerability of a Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders
Transverse-plane foot deformities are a frequently encountered issue in children with neurological disorders.
They are the source of many symptoms, such as pain and walking difficulties, making their prevention very important.
It is thus important to prevent the occurrence of transverse-plane foot deformities and limit their development regarding the high risk of morbidity.
In order to prevent such deformities, in the department of pediatric physical medicine and rehabilitation department of Lyon, since 2001 the investigator use a side pole static ankle foot orthosis (SPS AFO) in children with a neurological disorder predisposing such deformities.
The aim of the study this study is to describe the use, tolerability and potential side effects of this orthosis in children with neurological disorders from the investigator's department
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patient from the department of physical medicine and pediatric rehabilitation L'Escale (Lyon, France)
Description
Inclusion Criteria:
- regularly follow-up in the department of physical medicine and pediatric rehabilitation L'Escale (Lyon, France)
- presenting at least unilateral transverse-plane foot deformity within the context of a neurological disorder
- having a first prescription of SPS AFO between December 2001 and December 2011.
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of the SPS AFO wearing
Time Frame: At 3 months after SPS AFO implementation
|
Duration of the SPS AFO wearing
|
At 3 months after SPS AFO implementation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of the SPS AFO wearing
Time Frame: At 3 months after SPS AFO implementation
|
Frequency of the SPS AFO wearing
|
At 3 months after SPS AFO implementation
|
|
Duration of the SPS AFO wearing
Time Frame: At 1 year after SPS AFO implementation
|
Duration of the SPS AFO wearing
|
At 1 year after SPS AFO implementation
|
|
Frequency of the SPS AFO wearing
Time Frame: At 1 year after SPS AFO implementation
|
Frequency of the SPS AFO wearing
|
At 1 year after SPS AFO implementation
|
|
Duration of the SPS AFO wearing
Time Frame: at 2 year after SPS AFO implementation
|
Duration of the SPS AFO wearing
|
at 2 year after SPS AFO implementation
|
|
Frequency of the SPS AFO wearing
Time Frame: at 2 year after SPS AFO implementation
|
Frequency of the SPS AFO wearing
|
at 2 year after SPS AFO implementation
|
|
Duration of the SPS AFO wearing
Time Frame: At 4 years after SPS AFO implementation
|
Duration of the SPS AFO wearing
|
At 4 years after SPS AFO implementation
|
|
Frequency of the SPS AFO wearing
Time Frame: At 4 years after SPS AFO implementation
|
Frequency of the SPS AFO wearing
|
At 4 years after SPS AFO implementation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
January 1, 2012
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
May 2, 2017
First Submitted That Met QC Criteria
May 5, 2017
First Posted (Actual)
May 10, 2017
Study Record Updates
Last Update Posted (Actual)
May 10, 2017
Last Update Submitted That Met QC Criteria
May 5, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-68
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disorder
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Pôle Saint HélierINSA RennesCompleted
-
Pôle Saint HélierINSA RennesCompletedNeurological DisorderFrance
-
Collegium Medicum w BydgoszczyCompletedNeurological Complication of Procedure (Disorder)Poland
-
National Institute of Neurological Disorders and...CompletedNeurological DisorderUnited States
-
South West London and St George's Mental Health...CompletedFunctional Neurological Symptom DisorderUnited Kingdom
-
Forest Hills LabLiberyx Therapeutics Ltd.CompletedNeurological DisorderUnited States
-
Riphah International UniversityRecruitingNeurological DisorderPakistan
-
University Hospital, ToulouseCompleted
-
University of Colorado, DenverRecruitingFunctional Neurological DisorderCanada
Clinical Trials on No intervention as it is a observational study
-
Oxford University Hospitals NHS TrustCompleted
-
Assiut UniversityRecruitingPseudoexfoliation SyndromeEgypt
-
Beijing Tiantan HospitalCompleted
-
Beijing Tiantan HospitalHebei Medical University Third Hospital; Hengshui People's Hospital; Daxing Teaching...RecruitingInsomnia | Digestive EndoscopyChina
-
Beijing Tiantan HospitalHebei Medical University Third Hospital; Hengshui People's Hospital; Daxing Teaching...RecruitingInsomnia | Digestive EndoscopyChina
-
Children's Hospital of Fudan UniversityCompletedProlonged Mechanical VentilationChina
-
Istituti Clinici Scientifici Maugeri SpACompletedDepression | Cardiovascular Diseases | Anxiety | Rehabilitation | Psychological Distress | Pulmonary Disease | Coping BehaviorItaly
-
Cairo UniversityUnknownCovid19 | Diabete Type 2 | Non Diabetic Patients | Chest CT ScanEgypt
-
Hospital Sirio-LibanesCompletedEpipericardial Fat NecrosisBrazil
-
The University of Texas Health Science Center,...CompletedWound InfectionUnited States